Biopharmaceutical companies attend major overseas conferences in late May and early June. ASCO, EULAR, and BioUSA. During this period, it is said that key workers in the R&D and BD fields are not in Korea. Looking at BIO USA alone, more than 500 Korean companies participated in the event, second only to the US. It is truly a global conference. The purpose is to promote its own pipeline. Through this, it promotes achievements such as partnering and technology transfer. Intangible assets such as building a human network for future partnerships are also obtained.

Numerous companies announce their participation through press releases before overseas conferences. content is similar. They were 'invited' to t